DNA Mismatch Repair–deficient Endometrial Carcinosarcomas Portend Distinct Clinical, Morphologic, and Molecular Features Compared With Traditional Carcinosarcomas-Reference-Cited by-同舟云学术

DNA Mismatch Repair–deficient Endometrial Carcinosarcomas Portend Distinct Clinical, Morphologic, and Molecular Features Compared With Traditional Carcinosarcomas

Published:2020-08-14 Issue:11 Volume:44 Page:1573-1579
ISSN:0147-5185
Container-title:American Journal of Surgical Pathology
language:en
Short-container-title:

Author:

Segura Sheila E.,Pedra Nobre Silvana,Hussein Yaser R.,Abu-Rustum Nadeem R.,Weigelt Britta,Soslow Robert A.,DeLair Deborah F.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference37 articles.

1. Uterine carcinosarcomas: incidence and trends in management and survival;Arrastia;Gynecol Oncol,1997

2. Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus;Yamada;Cancer,2000

3. High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations;Murali;Int J Gynecol Pathol,2019

4. Integrated molecular characterization of uterine carcinosarcoma;Cherniack;Cancer Cell,2017

5. Immunohistochemical survey of mismatch repair protein expression in uterine sarcomas and carcinosarcomas;Hoang;Int J Gynecol Pathol,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Classification Outperforms Histologic Classification in Prognostication of High-grade Endometrial Carcinomas With Undifferentiated and Sarcomatous Components;American Journal of Surgical Pathology;2024-05-23

2. Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications;International Journal of Molecular Sciences;2024-01-15

3. Diseases Associated with Genetic Syndromes in Gynecologic Pathology;Gynecologic and Obstetric Pathology;2024

4. The expression of programmed death-ligand 1 and programmed death-ligand 2 in endometrial carcinosarcoma: Correlation with mismatch repair protein expression status, tumor-infiltrating lymphocyte infiltration, and clinical outcomes;Annals of Diagnostic Pathology;2023-08

5. Germline drivers of gynecologic carcinosarcomas;Gynecologic Oncology;2023-07